http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3084335-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7781e693e15562c9895ad11141935f1a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-26
filingDate 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6753738536b2322aad3aeba2c5be6cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_266f8494188b352826795d2374e41459
publicationDate 2019-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3084335-A1
titleOfInvention Process to continuously prepare a cyclic carbonate
abstract Process to continuously prepare a cyclic carbonate product by reacting an epoxide compound with carbon dioxide in the presence of a supported dimeric aluminium salen complex which complex is activated by a halide compound comprising the following steps, (a) contacting carbon dioxide with the epoxide compound in a suspension of liquid cyclic carbonate and the supported dimeric aluminium salen complex which complex is activated by a halide compound, (b) separating part of the cyclic carbonate product from the supported dimeric aluminium salen complex, (c) separating the halide compound from the cyclic carbonate product to obtain purified cyclic carbonate product, (d) use all or part of the halide compound as obtained in step (c) to activate deactivated supported dimeric salen complex.
priorityDate 2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426084234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414874221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416604284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415766543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762

Total number of triples: 48.